Simplex Trading’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
GS
SCM
VPM
VCM
WP
SL
Simplex Trading's RCUS Position: Q4 2025 in Review
Simplex Trading sold out of Arcus Biosciences (RCUS) in Q4 2025, closing a stake of 105,025 shares — an estimated $2.14M sold.
Simplex Trading first reported a position in RCUS in Q3 2019 and held it in 16 quarters. The position peaked at $2.53M in Q2 2023. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.
- Simplex Trading reported no remaining Arcus Biosciences position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 105,025 Arcus Biosciences shares in Q4 2025, an estimated $2.14M.
- Simplex Trading first reported a position in Arcus Biosciences in Q3 2019 and held it in 16 quarters.
- Simplex Trading's Arcus Biosciences position peaked at $2.53M in Q2 2023.
- 209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.